Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion description "[In a xenograft mouse model of human PC, CDF treatment significantly inhibited tumor growth, which was associated with decreased NF-?B DNA binding activity, COX-2, and miR-21 expression, and increased PTEN and miR-200 expression in tumor remnants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion evidence source_evidence_literature NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion SIO_000772 21408027 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion wasDerivedFrom befree-20140225 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_assertion wasGeneratedBy ECO_0000203 NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP880293.RAIrRz-pHhFXoPC25HM9nEbQd63N_V6O56vYwf77h9Evg130_provenance.